From: On the path to 2025: understanding the Alzheimer’s disease continuum
Examples of tools | |||
---|---|---|---|
Brief tools for general setting | Neuropsychological testing | Clinical trials | |
Clinically normal/SCI | CFI [55] | ADCS-PACCa [38] | |
FCI [56] | |||
MCI due to AD/prodromal AD | MIS [57] | FCSRT [58] | FCSRT [58] |
AD8 [59] | RBANS [63] | ADCOMa [60] | |
GPCOG [61] | CVLT [66] | FCI [56] | |
Mini-cog [62] | RBANS [63] | ||
CFI [55] | |||
MoCA [67] | |||
ACE III [68] | |||
MMSE [69] | |||
Dementia | MMSE [69] | ADAS-Cog [70] | ADAS-Cog [70] |
ACE III [68] | RBANS [63] | CDR [71] | |
RBANS [63] | |||
ADCS-ADL [53] | |||
SIB [72] | SIB [72] |